Journal of Stroke and Cerebrovascular Diseases 2008-Sep
Transdermal scopolamine to reduce salivation and possibly aspiration after stroke.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Веза се чува у привремену меморију
Кључне речи
Апстрактан
We report two cases illustrating a potential use of transdermal scopolamine to reduce salivation in acute stroke. We speculate that this may lead to reduced aspiration and possibly also less pneumonia. However, the treatment is associated with side effects. Finally, we suggest that this use of transdermal scopolamine in stroke may be a topic for a randomized clinical trial.
